Search Results 91-100 of 18933 for creatine

1. Study to Evaluate Mechanisms of Immunomodulator Sensitivity and Resistance in Multiple Myeloma - Mayo Clinic

   Creatinine clearance for males = (140 - age)(weight in kg) ( 72)(serum creatinine in mg/dL);; Creatinine clearance for females = (140 - age)(weight in kg ...

2. A Study to Determine Effectiveness and Safety of Ultrasound Shockwave Therapy for Post-Stenotic Microvascular Modeling - Mayo Clinic

   Patients have serum creatinine ≤2.2 mg/dL. Patients have no contraindications to angiography: severe contrast allergy. Patients have no contraindications ...

3. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors - Mayo Clinic

   Serum creatinine ≤ 1.5 x institutional ULN (within 28 days prior to registration);; Calculated creatinine clearance ≥ 50 ml/min (within 28 days prior to ...

4. Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) - Mayo Clinic

   ... creatinine. * For participants presenting from community, the reference serum creatinine should be estimated using the following order of preference: 1. The ...

5. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT - Mayo Clinic

   ... creatinine based on age/gender as follows (within 7 days prior to enrollment): - Age: Maximum serum creatinine (mg/dL); - 3 to < 6 years: 0.8 (male), 0.8 ...

6. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

   Creatinine OR Measured or calculated** creatinine clearance (GFR can also be used in place of creatinine or CrCl);; ≤1.5 × ULN OR ≥0 mL/min for participant ...

7. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

   ... creatinine (mg/dL);; Females: Creatinine CL = Weight (kg) × (140 - Age) × 0.85 (mL/min) 72 × serum creatinine (mg/dL). Must have a life expectancy of at ...

8. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

   Serum creatinine ≤ 1.5 x ULN, OR calculated creatinine clearance ≥ 30 mL/minute (modified Cockcroft and Gault formula); Urine protein to creatinine (UPC) ...

9. TruGraf® Long-term Clinical Outcomes Study

   Recipient of a primary or subsequent deceased-donor or living-donor kidney transplant. At least 1-year post-transplant (+/- 2 months). Stable serum creatinine ( ...

10. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

    Calculated creatinine clearance ≥ 30 ml/min using the Cockcroft-Gault formula below: Cockcroft-Gault Equation: Creatinine clearance for males = (140 - age)( ...